Terminal Sterilization Influences the Efficacy of an Extracellular Matrix-Blood Composite for Treating Post-Traumatic Osteoarthritis in the Rat Model
The objective was to determine if an intraarticular injection of an extracellular matrix (ECM) powder and blood composite (ECM-B) after anterior cruciate ligament (ACL) injury would have a mitigating effect on post-traumatic osteoarthritis, and if that effect would be different with terminal sterili...
Saved in:
Published in | Journal of orthopaedic research Vol. 40; no. 3; pp. 573 - 583 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
05.05.2021
|
Online Access | Get full text |
Cover
Loading…
Summary: | The objective was to determine if an intraarticular injection of an
extracellular matrix (ECM) powder and blood composite (ECM-B) after anterior
cruciate ligament (ACL) injury would have a mitigating effect on post-traumatic
osteoarthritis, and if that effect would be different with terminal
sterilization of the ECM powder prior to use. Eighty Lewis rats underwent ACL
transection and were divided into four groups: 1) intraarticular injection with
PBS (PBS;
n
= 20), 2) intraarticular injection of ECM-B using
aseptically processed ECM (ASEPTIC;
n
= 20), 3) intraarticular
injection of the ECM-B using ECM powder sterilized with 15 kGy electron beam
irradiation (EBEAM; n=20), and 4) intraarticular injection of the ECM-B using
ECM powder sterilized with ethylene oxide (EO; n=20). Twenty additional animals
received capsulotomy only (SHAM). Animals were followed for 6 weeks and
evaluations of gait, radiographs and joint cartilage histology were performed.
At 6 weeks, when compared to the SHAM group, the group treated with PBS had
significantly worse gait and histologic changes, while the ASEPTIC group was not
different from SHAM for either of these outcomes. When compared to the SHAM
group, the EO group had similar gait outcomes, but greater histologic damage,
and the EBEAM group had significantly worse gait and histological outcomes. The
ECM-B composite produced using aseptically processed ECM powder mitigated the
gait and histologic changes associated with osteoarthritis after ACL transection
in the rat; however, care must be taken when selecting a terminal sterilization
method as this may affect the effectiveness of treatment. |
---|---|
Bibliography: | All authors have made substantial contributions to the study design, acquisition, analyses or interpretation of the data, have contributed to drafting of the manuscript, and have read and approved the final submitted version. |
ISSN: | 0736-0266 1554-527X |
DOI: | 10.1002/jor.25056 |